Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 May;65(5):931-936.
doi: 10.1111/jgs.14716. Epub 2017 Mar 13.

Impact of the REACH II and REACH VA Dementia Caregiver Interventions on Healthcare Costs

Affiliations
Free PMC article
Randomized Controlled Trial

Impact of the REACH II and REACH VA Dementia Caregiver Interventions on Healthcare Costs

Linda O Nichols et al. J Am Geriatr Soc. 2017 May.
Free PMC article

Abstract

Objective: Examine caregiver and care recipient healthcare costs associated with caregivers' participation in Resources for Enhancing Alzheimer's Caregivers Health (REACH II or REACH VA) behavioral interventions to improve coping skills and care recipient management.

Design: RCT (REACH II); propensity-score matched, retrospective cohort study (REACH VA).

Setting: Five community sites (REACH II); 24 VA facilities (REACH VA).

Participants: Care recipients with Alzheimer's disease and related dementias (ADRD) and their caregivers who participated in REACH II study (analysis sample of 110 caregivers and 197 care recipients); care recipients whose caregivers participated in REACH VA and a propensity matched control group (analysis sample of 491).

Measurements: Previously collected data plus Medicare expenditures (REACH II) and VA costs plus Medicare expenditures (REACH VA).

Results: There was no increase in VA or Medicare expenditures for care recipients or their caregivers who participated in either REACH intervention. For VA care recipients, REACH was associated with significantly lower total VA costs of care (33.6%). VA caregiver cost data was not available.

Conclusion: In previous research, both REACH II and REACH VA have been shown to provide benefit for dementia caregivers at a cost of less than $5/day; however, concerns about additional healthcare costs may have hindered REACH's widespread adoption. Neither REACH intervention was associated with additional healthcare costs for caregivers or patients; in fact, for VA patients, there were significantly lower healthcare costs. The VA costs savings may be related to the addition of a structured format for addressing the caregiver's role in managing complex ADRD care to an existing, integrated care system. These findings suggest that behavioral interventions are a viable mechanism to support burdened dementia caregivers without additional healthcare costs.

Keywords: Alzheimer's disease; caregivers; cost; dementia; expenditures; healthcare utilization.

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Conflict of Interest Disclosures: Below is the checklist authors completed.

[Table: see text]

Figures

Figure 1
Figure 1
Study Participants

Comment in

  • Reply to: Over-REACHing Conclusions.
    Nichols LO, Martindale-Adams J, Zhu CW, Kaplan EK, Zuber JK, Lum J, Waters TM. Nichols LO, et al. J Am Geriatr Soc. 2017 Sep;65(9):2109-2110. doi: 10.1111/jgs.14984. Epub 2017 Jul 13. J Am Geriatr Soc. 2017. PMID: 28703906 Free PMC article. No abstract available.
  • Over-REACHing Conclusions.
    Weeks WB. Weeks WB. J Am Geriatr Soc. 2017 Sep;65(9):2108-2109. doi: 10.1111/jgs.14949. Epub 2017 Jul 13. J Am Geriatr Soc. 2017. PMID: 28703908 No abstract available.

Similar articles

Cited by 11 articles

Publication types